← Back to news

Markets

Cantor Fitzgerald Lifts Texas Instruments Inc (TXN) Price Target. Here’s Why

Y

Hewlett Packard Enterprise Co (HPE) Broadens ScanSource Deal. Juniper In Focus

Y

JEPI vs. JEPQ: Which Is the Better Buy in July?

Y

Salesforce vs ServiceNow: One Buys Back Shares, Other Buys Companies

Y

This Undervalued $40 Billion Company Is Ready To Soar

Y

Mexico’s trucking labor crunch intensifies, IRU warns

Y

Ondas Just Built Autonomous Defense Powerhouse With This Major Acquisition

Y

Amazon vs. Walmart vs. Costco: Which Is the Smartest Buy for the Second Half of 2026?

Y

$14,000 dog grooming bills and 25% pricier flights: How the K-shaped economy is punishing the middle class

Y

Tesla vs. BYD: Here Is My Pick in This EV Showdown

Y

Air Canada appoints SAS CEO Anko Van der Werff as next chief executive

Y

Lucid Motors’ Woes Run Much Deeper. Saudi Money Alone Won’t Solve Them.

Y

Here's What to Expect From Entergy’s Next Earnings Report

Y

FuelCell Energy Sinks 14%, Bloom Energy Slides 8% After $225M FCEL Share Sale Prices at $21; Plug Power Treads Water

Y

Why Super Micro Computer Fell Over 36% in June

Y

Broadening Trade Returns as Conflict Eases. Can It Outlast a Hawkish Fed and Fading Liquidity?

Y

Stocks Retreat on US-Iran Jitters

Y

Finance salaries rise 6% amid talent crunch: Controllers Council

Y

QDTE’s 48% Yield Is Shrinking Fast As Volatility Drops Below 17

Y

JPMorgan sees the writing on the wall for silver stock investors

Y

Lisbon or the Algarve: Where Does a $600,000 Portuguese Retirement Go Further?

Y

The One Number That Could Rewrite the Story for CoreWeave Stock

Y

This $6.9 Billion ETF Delivers Consistent Dividends Without Eroding Share Price Like Covered Calls

Y

Dow drops as Trump signals Iran ceasefire may be over

Y

State Street’s Triple Play: Capturing the U.S. Broad Market Benchmarks

Y

My Top Dividend Stock to Buy in July and Hold Forever

Y

Here’s Why Nvidia Might Be the New Value Play in Semiconductors

Y

Is Genmab A/S (GMAB) Stock Undervalued After Positive Epkinly DLBCL Trial Results?

Y

Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?

Y

Record Money Is Pouring Into Emerging Markets. This One Difference Could Decide Your Returns

Y

The Hour-Long Project We Never Would’ve Started

Y

Three Most Valuable Companies at $13 Trillion: Buy, Sell, or Hold

Y

Solo GP Ashley Smith announces second $25M fund to back startups in AI, security and more

Y

23andMe data breach settlement of $46.75 million approved

Y

Tech CEOs Ditch the AI Jobs Apocalypse Narrative

Y

AI confidence is on the rise despite cost concerns

Y

Interview: Citi’s Andrew James on private markets, portfolio resilience and long-term wealth creation

Y

Air Canada Picks Outsider as Next CEO to Rebuild Trust After Video Fallout

Y

Bank of America Says Clients Were Finally Buying Stocks Last Week

Y

UTM seals gas sales pact with Seplat and NNPC for Yoho FLNG project

Y

Micron Earnings: I Was Worried For Nothing (Rating Upgrade)

S

Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?

Y

Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?

Y

Is Insulet Corporation (PODD) Stock Still a Diabetes Device Growth Opportunity After Analyst Target Cut?

Y

Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval?

Y

Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?

Y

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?

Y

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Y

Want Anthropic Exposure Before the IPO? These 2 AI Giants Are Already There

Y

2 Great Developments for Ford but Not for Rivian and Lucid

Y